Continuous-flow left ventricular assist devices (LVADs) have revolutionized advanced heart
failure care. These compact, fully implantable heart pumps are capable of providing …

Importance The mortality rate for the most advanced forms of heart failure with medical
therapy alone remains unacceptably high at 30% to 80% at 1 year. In the past decade, left …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

Objectives: The purpose of this study was to determine the risk factors for ischemic in
hemorrhage cerebrovascular events in patients supported by the HeartWare ventricular …

Background Left ventricular assist devices (LVADs) are increasingly used in patients with
heart failure. To study the impact of stroke on clinical outcomes after continuous-flow (CF-) …

The accepted use of left ventricular assist device (LVAD) technology as a good alternative
for the treatment of patients with advanced heart failure together with the improved survival …

Background Stroke is one of the leading complications during continuous flow-left
ventricular assist device (CF-LVAD) support. Risk factors have been well described …

Background Stroke is a significant complication in patients supported with continuous-flow
left ventricular assist devices (CF-LVAD) and hypertension is a significant risk factor for …

Cerebral infarction and hemorrhage are among the principal sources of morbidity and
mortality associated with mechanical circulatory support. There has been particular concern …

The introduction of multiple new pharmacological agents over the past three decades in the
field of heart failure with reduced ejection fraction (HFrEF) has led to reduced rates of …